Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Green

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Circulation|August 14, 2013
Population pharmacokinetics of enoxaparin during the antenatal periodJignesh P Patel, Bruce Green, Raj K Patel, et al.
British Journal of Clinical Pharmacology|July 18, 2006
Development of a dosage strategy in patients receiving enoxaparin by continuous intravenous infusion using modelling and simulationYan Feng, Bruce Green, Stephen B Duffull, et al.
Research and Practice in Thrombosis and Haemostasis|July 27, 2018
The impact of body weight on rivaroxaban pharmacokineticsSarah J Barsam, Jignesh P Patel, Lara N Roberts, et al.
BMC Pregnancy and Childbirth|November 20, 2014
Changes in thrombin generation and D-dimer concentrations in women injecting enoxaparin during pregnancy and the puerperiumJignesh P Patel, Raj K Patel, Lara N Roberts, et al.
Journal of Clinical Pharmacology|April 10, 2016
Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Relationships of Etravirine in HIV-1-Infected, Treatment-Experienced Children and Adolescents in PIANOThomas N Kakuda, Anne Brochot, Bruce Green, et al.
HIV Clinical Trials|July 10, 2013
Pharmacokinetics and pharmacodynamics of etravirine 400 mg once daily in treatment-naïve patientsGiovanni Di Perri, Bruce Green, Glynn Morrish, et al.
The Journal of Spinal Cord Medicine|March 3, 2004
Intravesical resiniferatoxin for refractory detrusor hyperreflexia: a multicenter, blinded, randomized, placebo-controlled trialJang Hwan Kim, David A Rivas, Patrick J Shenot, et al.
Clinical Pharmacokinetics|November 26, 2008
Pharmacokinetics of sapropterin in patients with phenylketonuriaFrançois Feillet, Lorne Clarke, Concetta Meli, et al.
British Journal of Clinical Pharmacology|August 27, 2021
Population pharmacokinetics and dose optimisation of colecalciferol in paediatric patients with chronic kidney diseaseMandy Wan, Bruce Green, Arpana Aprameya Iyengar, et al.
Journal of Thrombosis and Haemostasis : JTH|June 9, 2020
Fixed dose rivaroxaban can be used in extremes of bodyweight: A population pharmacokinetic analysisVictoria Speed, Bruce Green, Lara N Roberts, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Circulation|August 14, 2013
Population pharmacokinetics of enoxaparin during the antenatal periodJignesh P Patel, Bruce Green, Raj K Patel, et al.
British Journal of Clinical Pharmacology|July 18, 2006
Development of a dosage strategy in patients receiving enoxaparin by continuous intravenous infusion using modelling and simulationYan Feng, Bruce Green, Stephen B Duffull, et al.
Research and Practice in Thrombosis and Haemostasis|July 27, 2018
The impact of body weight on rivaroxaban pharmacokineticsSarah J Barsam, Jignesh P Patel, Lara N Roberts, et al.
BMC Pregnancy and Childbirth|November 20, 2014
Changes in thrombin generation and D-dimer concentrations in women injecting enoxaparin during pregnancy and the puerperiumJignesh P Patel, Raj K Patel, Lara N Roberts, et al.
Journal of Clinical Pharmacology|April 10, 2016
Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Relationships of Etravirine in HIV-1-Infected, Treatment-Experienced Children and Adolescents in PIANOThomas N Kakuda, Anne Brochot, Bruce Green, et al.
HIV Clinical Trials|July 10, 2013
Pharmacokinetics and pharmacodynamics of etravirine 400 mg once daily in treatment-naïve patientsGiovanni Di Perri, Bruce Green, Glynn Morrish, et al.
The Journal of Spinal Cord Medicine|March 3, 2004
Intravesical resiniferatoxin for refractory detrusor hyperreflexia: a multicenter, blinded, randomized, placebo-controlled trialJang Hwan Kim, David A Rivas, Patrick J Shenot, et al.
Clinical Pharmacokinetics|November 26, 2008
Pharmacokinetics of sapropterin in patients with phenylketonuriaFrançois Feillet, Lorne Clarke, Concetta Meli, et al.
British Journal of Clinical Pharmacology|August 27, 2021
Population pharmacokinetics and dose optimisation of colecalciferol in paediatric patients with chronic kidney diseaseMandy Wan, Bruce Green, Arpana Aprameya Iyengar, et al.
Journal of Thrombosis and Haemostasis : JTH|June 9, 2020
Fixed dose rivaroxaban can be used in extremes of bodyweight: A population pharmacokinetic analysisVictoria Speed, Bruce Green, Lara N Roberts, et al.
Pageof 4